Skip to main navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
- Stock Quote & Chart
- Historical Price Lookup
Governance & Financials
Investor Resources

Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
- Stock Quote & Chart
- Historical Price Lookup
Governance & Financials
Investors Resources

Press Releases

Year

Dec 19, 2024

Climb Bio to be Added to the Nasdaq Biotechnology Index
Nov 12, 2024

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Nov 11, 2024

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
Oct 31, 2024

Climb Bio to Present at Upcoming Investor Conferences
Oct 15, 2024

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
Oct 11, 2024

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
Oct 04, 2024

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
Oct 03, 2024

Climb Bio to Host Virtual Investor Event on October 15, 2024
Oct 02, 2024

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
Sep 11, 2024

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 15

Contact Us

20 William Street, Suite 145, Wellesley Hills, MA 02481
1-866-857-CLYM (2596)

media@climbbio.com

investorrelations@climbbio.com

careers@climbbio.com

Policy

Privacy Policy

© 2024 Climb Bio^®. All Rights Reserved.